Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1126/scitranslmed.abd1525 http://scihub22266oqcxt.onion/10.1126/scitranslmed.abd1525 33536277!ä!33536277 Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Sci+Transl+Med 2021 ; 13 (579): ä Nephropedia Template TP {{tp|p=33536277|t=2021. Development and deployment of COVID-19 vaccines for those most vulnerable |pdf=|usr=}}{{33536277}} gab.com Text Development and deployment of COVID-19 vaccines for those most vulnerable JO: Sci Transl Med http://www.kidney.de/pget.php?&tw=1&pmid=33536277 #FOAvip Development of safe and effective COVID-19 vaccines is a global priority and the best hope for ending the COVID-19 pandemic. Remarkably, in less than 1 year, vaccines have been developed and shown to be efficacious and are already being deployed worldwide. Yet, many challenges remain. Immune senescence and comorbidities in aging populations and immune dysregulation in populations living in low-resource settings may impede vaccine effectiveness. Distribution of vaccines among these populations where vaccine access is historically low remains challenging. In this Review, we address these challenges and provide strategies for ensuring that vaccines are developed and deployed for those most vulnerable. Twit Text FOAVip Development and deployment of COVID-19 vaccines for those most vulnerable ????Sci Transl Med http://www.kidney.de/pget.php?&tw=1&pmid=33536277 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33536277 #FOAvip English Wikipedia <ref>{{Cite pmid|33536277}}</ref> Development and deployment of COVID-19 vaccines for those most vulnerable #MMPMID33536277 Koff WC; Schenkelberg T; Williams T; Baric RS; McDermott A; Cameron CM; Cameron MJ; Friemann MB; Neumann G; Kawaoka Y; Kelvin AA; Ross TM; Schultz-Cherry S; Mastro TD; Priddy FH; Moore KA; Ostrowsky JT; Osterholm MT; Goudsmit J Sci Transl Med 2021[Feb]; 13 (579): ä PMID33536277show ga Development of safe and effective COVID-19 vaccines is a global priority and the best hope for ending the COVID-19 pandemic. Remarkably, in less than 1 year, vaccines have been developed and shown to be efficacious and are already being deployed worldwide. Yet, many challenges remain. Immune senescence and comorbidities in aging populations and immune dysregulation in populations living in low-resource settings may impede vaccine effectiveness. Distribution of vaccines among these populations where vaccine access is historically low remains challenging. In this Review, we address these challenges and provide strategies for ensuring that vaccines are developed and deployed for those most vulnerable. |*Disease Susceptibility[MESH] |Animals[MESH] |COVID-19 Vaccines/adverse effects/*immunology[MESH] |COVID-19/*immunology/*virology[MESH] |Disease Models, Animal[MESH] |Humans[MESH] |Phylogeny[MESH]Development and deployment of COVID-19 vaccines for those most vulnera(epmc).pdf DeepDyve Pubget Overpricing